Premium
Cancer in the elderly in the C zech R epublic
Author(s) -
Petera J.,
Dušek L.,
Sirák I.,
Soumarova R.,
Jarkovsky J.
Publication year - 2015
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.12287
Subject(s) - medicine , incidence (geometry) , relative survival , cancer registry , cancer , population , epidemiology , radiation therapy , prostate cancer , surgery , physics , environmental health , optics
Population ageing presents a challenge to oncological care due to the particularities of cancer treatment in this population. We evaluate cancer epidemiology, treatment and survival, in the C zech R epublic by age groups. Data published by the C zech N ational C ancer R egistry from the years 2006 to 2010 were used for this study. The following cancer types were evaluated: colorectal, pancreatic, head and neck, lung, skin melanoma, breast, gynaecological, prostate, kidney and stomach cancers. The following data were recorded and analysed: crude incidence by 5‐year age group; dynamics of crude incidence rates in the age group ≥70 years; disease stage; percentage of patients treated by surgery, radiotherapy and chemotherapy; and age standardised 1‐year mortality and 5‐year relative survival according to age group. Patients over age 70 accounted for 41% and 46%, respectively, of the cancer incidence and mortality of the whole population. Anticancer therapies are significantly less common in patients over age 70 ( P < 0.050), with the exception of skin melanoma. Survival was markedly worse in older patients ( P < 0.050) when radical treatment modalities were significantly underused ( P < 0.050). In the C zech R epublic, the crude cancer incidence in seniors is increasing. In general, elderly patients are undertreated, with worse treatment results compared with younger patients.